JavaScript is NOT enabled !

Please enable JavaScript.

Article

FT
PubMed

This record comes from PubMed

Europe immunoglobulin map

Šedivá, A
Author Šedivá, A Department of Immunology, Motol University Hospital and 2nd Faculty of Medicine, Charles University, Prague, Czech Republic
Chapel, H
Author Chapel, H
Gardulf, A
Author Gardulf, A
European Immunoglobulin Map Group (35 European Countries) for European Society for Immunodeficiencies (ESID) Primary Immunodeficiencies Care in Development Working Party
Author European Immunoglobulin Map Group (35 European Countries) for European Society for Immunodeficiencies (ESID) Primary Immunodeficiencies Care in Development Working Party

Clinical and experimental immunology. 2014 Dec ; 178 Suppl 1 (Suppl 1) : 141-3.

Clin Exp Immunol
ISSN 1365-2249 | 0009-9104
Source

Language English Country Great Britain, England Media print

Document type Journal Article

Persistent link https://www.medvik.cz/link/pmid25546797

Online Full text

PubMed 25546797
PubMed Central PMC4285526
DOI 10.1111/cei.12546
Knihovny.cz E-resources

MeSH
Immunoglobulins immunology therapeutic use MeSH
Immunoglobulins, Intravenous immunology therapeutic use MeSH
Humans MeSH
Immunization, Passive methods MeSH
Infusions, Subcutaneous methods MeSH
Immunologic Deficiency Syndromes immunology therapy MeSH
Check Tag
Humans MeSH
Publication type
Journal Article MeSH
Geographicals
Europe MeSH
Names of Substances
Immunoglobulins MeSH
Immunoglobulins, Intravenous MeSH

Department of Immunology Motol University Hospital and 2nd Faculty of Medicine Charles University Prague Czech Republic

See more in PubMed

Chapel H, Gardulf A. Subcutaneous immunoglobulin replacement therapy: the European experience. Curr Opin Allergy Clin Immunol. 2013;13:623–629. PubMed

Gardulf A, Nicolay U, Math D, et al. Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home. J Allergy Clin Immunol. 2004;114:936–942. PubMed

Sewell WA, Kerr J, Behr-Gross ME, Peter HH. European consensus proposal for immunoglobulin therapies. Eur J Immunol. 2014;44:2207–2214. PubMed

Newest 20 citations...

See more in
Medvik | PubMed

Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies

Frontiers in immunology. 2019 ; 10 () : 40. [epub] 20190204

Front Immunol
ISSN 1664-3224
Source

Borrow
RIS

Find record

In BMC

Citation metrics

Logged in users only

Europe immunoglobulin map

Find record

Citation metrics

Archiving options